Nemesis Bioscience

Developer of therapeutics to reverse microbial resistance to antibiotics

placeCambridge, England, United Kingdom calendar_todayFounded 2014 groups8 employees language nemesisbio.com

Registered entities

Investor mix

39 investors on record; lead investors include UK Innovation Science & Seed Fund, Shionogi, Coastal International, Wren Capital.

Investor typeCountShare
Venture capital38%
Private equity13%
Accelerator & incubator13%
Other / undisclosed3487%
Coming soon